Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
3,05 USD | -1,61% | -6,15% | -47,41% |
Attività
Numero di dipendenti: 46
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Compounds
100,0
%
| 41 | 100,0 % | 49 | 100,0 % | +19,95% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 41 | 100,0 % | 49 | 100,0 % | +19,95% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 07/03/14 |
Justin File
DFI | Director of Finance/CFO | 53 | 12/06/23 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/22 |
Eric Deng
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/21 |
Jason Sausser
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/22 |
Richard Ghalie
CTO | Chief Tech/Sci/R&D Officer | 66 | 01/03/16 |
David Walsey
IRC | Investor Relations Contact | - | 01/02/18 |
Eugene Park
SAM | Sales & Marketing | - | 01/07/21 |
Anne Frese
HRO | Human Resources Officer | - | 22/06/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 26/02/18 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 11/02/13 |
Charles Baltic
CHM | Chairman | 63 | 20/10/11 |
Nick Glover
BRD | Director/Board Member | 55 | 11/06/13 |
David Urso
CEO | Chief Executive Officer | 60 | 07/03/14 |
Steven Wood
BRD | Director/Board Member | 41 | 31/10/23 |
Director/Board Member | 33 | 31/10/23 | |
James Flynn
BRD | Director/Board Member | 43 | 31/10/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 6 662 857 | 6 627 017 ( 99,46 %) | 0 | 99,46 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-47,41% | 20,32 Mln | |
+1,51% | 42,75 Mrd | |
+8,57% | 41,34 Mrd | |
+49,22% | 41,61 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione MEIP
- Società MEI Pharma, Inc.